ContraFect (NASDAQ:CFRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research report released on Sunday. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Stock Up 16.7 % NASDAQ:CFRX opened at $0.07 on Friday. The firm has a 50 day moving average of $0.44 and a 200 day moving […]

Leave a Reply

Your email address will not be published.

Previous post Global Indemnity Group (NASDAQ:GBLI) Receives New Coverage from Analysts at StockNews.com
Next post Suzuki Five out of five for the new Jimny